二维与三维超声用于肿瘤体积分析:一项前瞻性研究
该前瞻性研究比较二维与三维超声相对于MRI测量乳腺癌新辅助化疗前后肿瘤体积的相关性,发现≤20 cm³肿瘤两者与MRI高度相关,20–40 cm³二维超声差异在观察者间变异范围内而三维超声超出,>40 cm³相关性差。
要点
- ≤20 cm³肿瘤二维与三维超声体积与MRI相关性均好,RPD在观察者间变异范围内。
- 20–40 cm³肿瘤二维超声RPD 13%在观察者间变异范围内,三维超声RPD 27%超出。
- >40 cm³肿瘤超声与MRI体积相关性差。
核心结论
- ≤20 cm³肿瘤体积与MRI相关性好,20–40 cm³二维超声差异在观察者间变异范围内提示有临床实用性,>40 cm³相关性差,临床应用研究有待开展。
研究设计与样本
- 前瞻性机构审查委员会批准的临床评估,比较超声与MRI体积相关性,纳入新辅助化疗前后乳腺癌患者,42例中170次超声检查有133次可评估。
关键影像表现/征象
- 二维与三维超声测量肿瘤体积,以MRI为参考比较体积差异。
诊断标准与关键数值
- ≤20 cm³肿瘤二维与三维超声与MRI高度相关,Pearson相关系数最高0.86(新辅助化疗前0.80,化疗后0.86),RPD在观察者间变异范围内。
- 20–40 cm³肿瘤二维超声RPD 13%(在观察者间变异范围内),三维超声RPD 27%(超出观察者间变异范围),体积标准误二维超声1.47 cm³、三维超声2.28 cm³。
- >40 cm³肿瘤与MRI相关性差。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文结论指出临床应用研究有待开展(Studies of clinical applications are warranted)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ultrasound (US) allows real-time tumor assessment. We evaluated the volumetric limits of 2-D and 3-D US, compared with magnetic resonance imaging (MRI), with a prospective institutional review board-approved clinical evaluation of US-to-MRI volumetric correlation. US images of pre- and post-neoadjuvant breast cancers were obtained. Volume discrepancy was evaluated with the non-parametric Wilcoxon signed-rank test. Expected inter-observer variability <14% was evaluated as relative paired difference (RPD); clinical relevance was gauged with the volumetric standard error of the mean (SEM). For 42 patients, 133 of 170 US examinations were evaluable. For tumors ≤20 cm3, both highly correlated to MRI with RPD within inter-observer variability and Pearson's correlation up to 0.86 (0.80 before and 0.86 after neoadjuvant chemotherapy, respectively). Lesions 20-40 cm3 had US-to-MRI discrepancy within inter-observer variability for 2-D (RPD: 13%), but not 3-D (RPD: 27%) US (SEM: 1.47 cm3 for 2-D, SEM: 2.28 cm3 for 3-D), suggesting clinical utility. Tumors >40 cm3 correlated poorly. Tumor volumes ≤20 cm3 exhibited a good correlation to MRI. Studies of clinical applications are warranted.
引用
- González SJ, Mooney B, Lin HY, et al. 2-D and 3-D Ultrasound for Tumor Volume Analysis: A Prospective Study. Ultrasound Med Biol. 2017. PMID: 28187928. doi:10.1016/j.ultrasmedbio.2016.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。